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Response to Shaheen et al.
To the Editor: Thank you for the opportunity to respond to
the Letter to the Editor, ‘‘FKBP10 and Bruck Syndrome:
Phenotypic Heterogeneity or Call for Reclassification?’’ by
Shaheen et al. The findings in the two patients described
are interesting and provide more information about the
correlation between FKBP10 (MIM 607063) mutations
and phenotype, which is important from a clinical perspec-
tive. The index patient has severe osteopenia with flexion
deformity and was originally thought to have arthrogrypo-
sis multiplex congenita. These findings are highly sugges-
tive of Bruck syndrome (MIM 259450 and 609220), a rare
form of osteopenia with congenital contractures that is
similar to some forms of OI. However, the patients
described in the Alanay et al. 2010 paper did not present
with the same phenotypic findings.
We have reviewed the findings in six of our seven
Turkish patients with homozgyosity for an FKBP10 muta-
tion leading to an in-frame p.delGly107_Leu117 deletion
and our three Mexican-American patients who were
homozygous for a null mutation. All of these patients
were diagnosed with osteogenesis imperfecta soon after
birth, and all were noted to have excessive joint laxity
with neither contractures nor, more importantly, ptery-
gium. Because pterygium was not observed, we infer that
there was in utero movement across the joints. Follow-up
examination of the Mexican-American family revealed
that two of the patients developed contractures at the
elbows. Whether the contractures were the direct result
of abnormalities in FKBP65 (the protein encoded by the
FKBP10 gene) function or a secondary result of chronic
dislocations leading to contractures is unknown.
Shaheen et al. suggest that in the Alanay et al., 2010
article the contractures at the elbow in Figure 2B and the
pes planus in Figure 2A are due to ‘‘developmental’’
contractures and thus that the disorder should be reclassi-
fied. Radiographs in Figure 2H show severely deformed
extremities with a dislocation at the elbow. Because the
dislocation was not noted at birth or in the neonatal
period, it is our view that any contracture at the elbow
would be secondary. Indeed, there are many disorders
with chronic joint dislocations that lead to a contracture
with ‘‘webbing’’ over the unused joint.
Shaheen et al. identify a mutation in FKBP10 that alters
the third PPIase domain of the FKBP65 molecule. Whether
the mutation leads to reduced or absent FKBP65 activity is
not clear.However, as inmanydisorders, awide phenotypic308 The American Journal of Human Genetics 87, 306–308, August 1range of severity can result from different mutations in the
same gene. In addition, variability due to the influences of
genetic background might also affect phenotypic expres-
sion. We welcome further expansion of the phenotypes
associated with FKBP10 mutations because there is so
much to learn about the molecule. Previous work on
FKBP65 has shown that it has roles in the function of
both type I collagen and tropoelastin, and probably other
proteins as well, suggesting that much work needs to be
done with regard to the role of FKBP65 in mesenchymal-
derived tissues in addition to its function in bone.
The issues of semantics and splitters versus lumpers are
of on-going debate in the genetics community. There is
probably no unified answer to these issues because clinical
interpretation occurs over an ever-changing landscape of
disease progression and molecular advances. Demon-
strating variation in phenotype is important, but categoriz-
ing patients into a rare new subgroup with an eponym that
does not delineate the phenotype does not serve either the
clinical genetics or molecular genetics communities and
could lead to confusion. We suggest the phenotype that
we have studied and found to be due to mutations in
FKBP10 be categorized as a recessive form of progressive de-
forming osteogenesis imperfecta with or without joint
contractures and that it be recognized that there is a spec-
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